First Financial Equity Corporation’s GSK GSK Stock Holding History

First Financial Equity Corporation’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$214K	Buy	+4,028	New	+$204K	0.04%	393

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

First Financial Equity Corporation's GSK Position: Q1 2017 in Review

First Financial Equity Corporation opened a new position in GSK (GSK) in Q1 2017: 4,028 shares worth $214K. The stake represents 0.04% of the portfolio and ranks #393 among its holdings.

786 funds tracked by Wall St. Rank hold GSK as of Q1 2017.

First Financial Equity Corporation held 4,028 shares of GSK worth $214K as of Q1 2017.
GSK was a new First Financial Equity Corporation position in Q1 2017.
GSK made up 0.04% of First Financial Equity Corporation's portfolio in Q1 2017, its #393 holding.
786 funds tracked by Wall St. Rank held GSK as of Q1 2017.

Based on First Financial Equity Corporation's 13F filing for Q1 2017, filed 16 May 2017.